Sensome develops microsensing technology for real-time intra-operative tissue analysis.
Its technology combines an impedance-based sensor with predictive algorithms to identify and characterize biological tissues in situ. The technology can be incorporated into a variety of medical devices.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Initial applications include identifying cancerous lung tumors during biopsy and characterizing clots involved in ischemic stroke and peripheral vascular disease.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 21, 2026, September 27, 2026 and September 29, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.